Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Sales | 1,895 | 1,736 | 2,300 | 2,209 | 2,843 |
| Cost of Goods | 3,330 | N/A | N/A | 3,350 | 4,005 |
| Gross Profit | -1,430 | 1,736 | 2,300 | -1,141 | -1,162 |
| Operating Expenses | 2,130 | 0 | 1,470 | 1,880 | 1,625 |
| Operating Income | -3,235 | 1,736 | 830 | -2,671 | -2,782 |
| Interest Expense | 430 | 0 | 270 | 270 | 260 |
| Other Income | 1,885 | -7,996 | -3,320 | 91 | -98 |
| Pre-tax Income | -1,780 | -6,260 | -2,760 | -2,850 | -3,140 |
| Net Income Continuous | -1,781 | -6,248 | -2,760 | -2,858 | -3,147 |
| Net Income | $-1,781 | $-6,248 | $-2,760 | $-2,858 | $-3,147 |
| EPS Basic Total Ops | -6.50 | -23.00 | -10.00 | -10.50 | -12.00 |
| EPS Basic Continuous Ops | -6.51 | -23.00 | -10.20 | -10.57 | -12.14 |
| EPS Diluted Total Ops | -6.50 | -23.00 | -10.00 | -10.50 | -12.00 |
| EPS Diluted Continuous Ops | -6.51 | -23.00 | -10.20 | -10.57 | -12.14 |
| EBITDA(a) | $-2,945 | $1,736 | $830 | $-2,671 | $-2,782 |